Position in PEN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$214,078
-$493,849 QoQ
Shares Held
678
-77.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#331
of 445 holders
Holding Since
Sep 2024
3 quarters on record
Voting authority
Sole 87%
Shared 13%
None 0%
Common Shares in PEN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Savant Capital, LLC holds $52,706,142 across 13 Medical Devices names. PEN ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
217,380 | $19,725,061 | |
| 2 | SYK |
Stryker Corp
|
57,029 | $17,955,010 | |
| 3 | BSX |
Boston Scientific Corp
|
124,870 | $5,329,451 | |
| 4 | MDT |
Medtronic plc
|
38,763 | $3,032,429 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
26,575 | $1,701,065 | |
| 6 | EW |
Edwards Lifesciences Corp
|
16,100 | $1,456,406 | |
| 7 | DXCM |
Dexcom Inc
|
15,175 | $1,022,036 | |
| 8 | STE |
STERIS plc
|
4,122 | $867,969 |
All Filings in PEN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,078 | 678 | Shares | Sole | 2026-08-10 | |
| 2024-12-31 | $707,927 | 2,981 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $536,295 | 2,760 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||